¥8.47
+ ¥0.02 (0.24%)
End-of-day quote: 05/17/2024
SZSE:002038

Beijing SL Pharmaceutical Annual Report

Year Year 2023 2004 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Rev. Revenue
¥1.02B ¥93.05M ¥2.17B ¥1.24B ¥1.01B ¥1.16B ¥1.24B ¥1.16B ¥1.01B ¥622.77M ¥457.84M ¥390.02M ¥358.00M ¥237.53M ¥146.12M ¥118.56M
GM % Gross Margin %
81.56% 65.12% 79.22% 70.52% 65.00% 65.86% 69.89% 67.16% 66.66% 75.39% 76.68% 82.83% 86.30% 65.64% 63.22% 61.28%
OM Operating Margin
24.56% 36.27% 30.52% 30.03% 44.98% 49.73% 57.31% 51.94% 51.35% 58.44% 56.26% 61.54% 65.17% 39.75% 32.59% 28.25%
EPS Earnings Per Share
¥0.00 ¥0.23 ¥0.54 ¥0.33 ¥0.41 ¥0.51 ¥0.62 ¥0.53 ¥0.45 ¥0.32 ¥0.24 ¥0.26 ¥0.22 ¥0.13 ¥0.03 ¥0.03 ¥0.03
Div. Dividends
¥0.15 ¥0.00 ¥0.20 ¥0.33 ¥0.13 ¥0.13 ¥0.13 ¥0.09 ¥0.09 ¥0.07 ¥0.06 ¥0.05 ¥0.05 ¥0.00 ¥0.00 ¥0.00
PR % Payout Ratio %
65.22% 0 37.04% 100.00% 31.71% 25.49% 20.97% 16.98% 20.00% 21.88% 25.00% 19.23% 22.73% 0 0 0
Sha. Shares
983.1m 1006.02m 1027.35m 1027.35m 1027.35m 1027.35m 1027.35m 1027.89m 1027.89m 1027.89m 1024.57m 1018.17m 1006.02m 1006.02m 1006.02m 1006.02m
OCF Operating Cash Flow
¥460.20M ¥0.00M ¥485.17M ¥383.01M ¥396.86M ¥504.87M ¥465.00M ¥347.41M ¥398.60M ¥228.59M ¥238.13M ¥174.41M ¥194.32M ¥88.36M ¥60.78M ¥47.48M
FCF Free Cash Flow
¥241.84M ¥0.00M ¥257.80M ¥153.36M ¥232.65M ¥375.19M ¥314.24M ¥237.93M ¥150.71M ¥155.54M ¥195.09M ¥143.95M ¥170.71M ¥61.75M ¥-4.17M ¥-33.76M
FCFS Free Cash Flow Per Share
¥0.24 ¥0.00 ¥0.25 ¥0.15 ¥0.23 ¥0.37 ¥0.31 ¥0.23 ¥0.15 ¥0.15 ¥0.19 ¥0.14 ¥0.17 ¥0.06 ¥-0.00 ¥-0.03